Using Net Benefits to Report Cost-Effectiveness Results, PPT by K. O

Presentation at ISPOR Europe, Nov. 2011, by Ken O’Day, PhD, Director, Xcenda, LLC, Palm Harbor, FL, USA; Denise Globe, PhD, Senior Director, Global Health Outcomes Strategy and Research, Allergan, LLC, Irvine, CA, USA

You might also be interested in:

Moving Forward with HCEI, FDA’s 2017 Guidance October 19, 2017
Drugmakers Kick Off 2018 with Price Hikes January 3, 2018
Xcenda White Paper Analyzes 4 Medicare Part B Strengths May 3, 2018
ISPOR Announces ‘Women in Health Economics and Outcomes… November 12, 2017
Xcenda Releases HTA Quarterly Newsletter March 22, 2018
HTA in Europe: Key Success Factors for Positive HTA Recommendations June 21, 2018
TEDMED 2018 Welcomes 2 New Speakers September 10, 2018